Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the interventional cardiology market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor, a cathlab integration and intuitive workflow. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a direct sales force to distributors in the United States, Japan, Canada, and internationally. The company is headquartered in Québec, Canada.
This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol OPSSF.
This company has cross-listed shares that trade in the U.S. as the symbol OPSSF.
1.66 CAD
As of 03/17/2023
2022 © Stock Market MBA, Inc.